SCHEMBL5145428

SCHEMBL5145428

CCNC(=O)Nc1ccc(-n2c3c(c4ccccc42)C(=O)CCC3)c(Cl)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DOT1L Q8TEK3 1/20 0.45
HDAC1 Q13547 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
NR1I3 Q14994 1/20 0.38
RAB9A P51151 1/20 0.38
CHRM1 P11229 2/20 0.38
NPY2R P49146 1/20 0.37
CHRM5 P08912 1/20 0.37
CHRM3 P20309 1/20 0.37
BUB1 O43683 1/20 0.37
DDB1 Q16531 2/20 0.37
CRBN Q96SW2 2/20 0.37
PTGS1 P23219 1/20 0.36
PTGS2 P35354 1/20 0.36
S1PR1 P21453 1/20 0.36
CYP2D6 P10635 2/20 0.36
GRM4 Q14833 1/20 0.36
CYP2C9 P11712 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5147107 0.89 CYP2D6 (0.48) HDAC1HDAC6RAB9ACHRM1CYP2D6
SCHEMBL5148161 0.88 TP53 (0.41) HDAC1HDAC6RAB9APTGS1PTGS2
SCHEMBL5147134 0.87 LMNA (0.45) HDAC1HDAC6PTGS1PTGS2GRM4
SCHEMBL5147135 0.85 HDAC1 (0.43) HDAC1HDAC6RAB9ACHRM1NPY2R
SCHEMBL5147078 0.77 HDAC1 (0.48) HDAC1HDAC6PTGS1PTGS2GRM4
SCHEMBL5148480 0.76 PTGS1 (0.44) HDAC1HDAC6RAB9APTGS1PTGS2
SCHEMBL14422443 0.75 TP53 (0.41) HDAC1HDAC6RAB9ANPY2RGRM4
SCHEMBL4771960 0.75 CYP3A4 (0.43) HDAC1HDAC6PTGS1PTGS2GRM4
SCHEMBL5145359 0.73 GRM4 (0.35) RAB9ACHRM1NPY2RCHRM5CHRM3
SCHEMBL5145355 0.73 GRM4 (0.35) RAB9ACHRM1NPY2RCHRM5CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US claimed
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US disclosed
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US disclosed
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US disclosed
WO-2007035620-A2 CARBAZOLE DERIVATIVES SERENEX, INC. (US) 2007-03-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185184-A1 Carbazole derivatives CCNI, MKI67, CCNB3 DOT1L 391/4885HDAC1 145/4885HDAC6 204/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.